6-((6-(1-Ethyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b][1,2,4]triazin-3-yl)methyl)quinoline

ID: ALA3799924

Chembl Id: CHEMBL3799924

PubChem CID: 57405876

Max Phase: Preclinical

Molecular Formula: C19H16N8

Molecular Weight: 356.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCn1cc(-c2cnc3nnc(Cc4ccc5ncccc5c4)n3n2)cn1

Standard InChI:  InChI=1S/C19H16N8/c1-2-26-12-15(10-22-26)17-11-21-19-24-23-18(27(19)25-17)9-13-5-6-16-14(8-13)4-3-7-20-16/h3-8,10-12H,2,9H2,1H3

Standard InChI Key:  JETQBCUUZYCKST-UHFFFAOYSA-N

Associated Targets(Human)

MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Met TPR/MET fusion protein (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 356.39Molecular Weight (Monoisotopic): 356.1498AlogP: 2.54#Rotatable Bonds: 4
Polar Surface Area: 86.68Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.49CX LogP: 1.67CX LogD: 1.67
Aromatic Rings: 5Heavy Atoms: 27QED Weighted: 0.49Np Likeness Score: -2.05

References

1. Zhan Z, Peng X, Liu Q, Chen F, Ji Y, Yao S, Xi Y, Lin Y, Chen T, Xu Y, Ai J, Geng M, Duan W..  (2016)  Discovery of 6-(difluoro(6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazin-3-yl)methyl)quinoline as a highly potent and selective c-Met inhibitor.,  116  [PMID:27061987] [10.1016/j.ejmech.2016.03.076]

Source